Key Record Dates
ClinicalTrials.gov Identifier: | NCT03713632 |
---|---|
Brief Title: | Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) (SUNRISE) |
First Submitted : | October 18, 2018 |
First Submitted that Met QC Criteria : | October 19, 2018 |
First Posted : | October 22, 2018 |
Results First Submitted : | July 12, 2023 |
Results First Submitted that Met QC Criteria : | July 12, 2023 |
Results First Posted : | August 2, 2023 |
Certification/Extension First Submitted : | July 13, 2021 |
Certification/Extension First Submitted that Met QC Criteria : | July 13, 2021 |
Certification/Extension First Posted : | July 16, 2021 |
Last Update Submitted that Met QC Criteria : | October 10, 2023 |
Last Update Posted : | November 1, 2023 |